In the EV-303/KEYNOTE-905 study, the combination of nectin-4-directed antibody-drug conjugate (ADC) Padcev (enfortumab ...

Pfizer (NYSE: PFE) is a case in point, with its forward dividend yield of 7%. Although the stock is a favorite for many ...

Covid-19 levels are on the rise in the US, with transmission increasing in at least 45 states. Yet people who want to get vaccinated this fall may face a growing set of obstacles. Last week, the CDC ...

Pfizer launches PCV20 for adults in India to offer broad protection against pneumococcal disease: Our Bureau, Mumbai Wednesday, August 13, 2025, 15:45 Hrs [IST] Pfizer has announc ...

Pfizer Inc. has just upgraded its 2025 earnings forecast, fueling a bullish sentiment among analysts. After its Q2 earnings ...

Construction on the site will begin in the fall and is expected to be finished by 2027. North Chicago is already home to ...

Parents in the United States who want to vaccinate their young children against Covid-19 this fall may face a growing set of ...

The Food and Drug Administration (FDA) may not re-authorize Pfizer's COVID vaccine for children under the age of 5, the ...

Pfizer, Inc. (PFE) stock is incredibly cheap following management's raise of its 2025 adjusted earnings per share guidance.

Padcev, an antibody-drug conjugate which Pfizer acquired via its $43 billion Seagen deal, could help people who don’t qualify ...

In search of a better approach to designing and developing these small proteins, researchers turned to ProtGPT2.

The FDA cautions the outcomes described in the complaints may have no connection to the drugs or could be unexpected side effects.